SAM
HRTX icon

Simplify Asset Management’s Heron Therapeutics HRTX Stock Holding History

Simplify Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-431,590
Closed -$445K – 128
2023
Q3 		$445K Buy
431,590
+150,000
+53% +$213K 0.05% 97
2023
Q2 		$327K Sell
281,590
-25,000
-8% -$44.6K 0.04% 98
2023
Q1 		$463K Buy
+306,590
New +$768K 0.07% 85

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Simplify Asset Management's HRTX Position: Q4 2023 in Review

Simplify Asset Management sold out of Heron Therapeutics (HRTX) in Q4 2023, closing a stake of 431,590 shares — an estimated $445K sold.

Simplify Asset Management first reported a position in HRTX in Q1 2023 and held it in 3 quarters. The position peaked at $463K in Q1 2023. 151 funds tracked by Wall St. Rank hold HRTX as of Q4 2023.

  • Simplify Asset Management reported no remaining Heron Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Simplify Asset Management sold 431,590 Heron Therapeutics shares in Q4 2023, an estimated $445K.
  • Simplify Asset Management first reported a position in Heron Therapeutics in Q1 2023 and held it in 3 quarters.
  • Simplify Asset Management's Heron Therapeutics position peaked at $463K in Q1 2023.
  • 151 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2023.

Based on Simplify Asset Management's 13F filing for Q4 2023, filed 12 Feb 2024.